Method of and apparatus for investigating tissue histology

• US 7,054,674 B2
• Filed: 01/12/2001
• Issued: 05/30/2006
• Est. Priority Date: 11/19/1996
• Status: Expired due to Fees

• Current Assignee: MedX Health Corporation
• Original Assignee: Astron Clinica Ltd. (Boston Scientific Corporation)
• Inventors: Cane, Michael Roger, Beadman, Michael Andrew, Cotton, Symon D'Oyly
• Primary Examiner(s): Smith, Ruth S.
• Application Number:
  US09/760,387
• Publication Number:
  US 20010056237A1
• Time in Patent Office: 1,964 Days
• Field of Search: 600/407, 600/473, 600475-478, 600/410, 600/476, 382/128
• US Class Current: 600/407
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/1072 measuring distances on the body, e.g. measuring length, height or thickness A61B5/1076 takes precedence
• CPC Class Codes: A61B 5/1075 for measuring dimensions by non-invasive methods, e.g. for determining thickness of tissue layer A61B8/0858 takes precedence
• CPC Class Codes: A61B 5/443 Evaluating skin constituents, e.g. elastin, melanin, water
• CPC Class Codes: A61B 5/444 Evaluating skin marks, e.g. mole, nevi, tumour, scar
• CPC Class Codes: A61B 5/445 Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence
• CPC Class Codes: G01N 21/359 using near infrared light

Abstract

Apparatus for monitoring the presence of one or more chromophores in a tissue sample, comprises a light source for projecting light to illuminate an area of such tissue sample, a photo-receptor for receiving light remitted by the illuminated area of tissue, and spectroscopic analyser means for monitoring the remitted light, a comparator having means for comparing variations in the intensity and spectral characteristics of the remitted light with respect to the intensity and spectral characteristics of the projected light at different wavelengths and with a record of the intensity and spectral characteristics of light remitted by a reference sample of such tissue and means for emitting a control signal in response to any such variations. Methods of analyzing tissue histology, especially skin histology, are discussed, and a mathematical model is proposed for the analysis and comparison of the remitted light with a reference sample.

Claims

1. A method of monitoring the presence of one or more chromophores in a sample of biological tissue, which method comprises:

illuminating an area of such tissue sample by projecting light from a light source;

receiving light remitted by the illuminated area of tissue at a photo-receptor;

spectroscopically analyzing the light projected from the light source and the remitted light received by the photo-receptor and utilizing said analysis to generate data indicative of differences between light projected from the light source and the remitted light;

using the generated data to define a parameter of the tissue;

processing the generated data using a predictive mathematical model of the optical properties of the biological tissue to normalize the defined parameter defined by the generated data to a standard value of that parameter; and

measuring at least one further parameter of the tissue using said processed data processed to normalize the defined parameter defined by the generated data to a standard value.

2. A method according to claim 1 applied for non-invasive monitoring of the presence of one or more said chromophores in the tissue sample.

3. A method according to claim 2, applied for controlling a treatment which involves the irradiation of a region of tissue with treatment light of predetermined spectral characteristics, wherein the absorption characteristics of tissue supervening the region to be treated for the treatment light are measured and used in calculating a required exposure of the tissue to the treatment light.

4. A method according to claim 2, applied for predicting the outcome of a treatment which involves the irradiation of a region of tissue with treatment light of predetermined spectral characteristics, wherein the absorption characteristics for the treatment light of the tissue region to be treated and of tissue supervening the region to be treated are measured and used in calculating a required therapeutically effective exposure of the tissue to the treatment light, and the required exposure and the absorption characteristics of the supervening tissue are used to predict potential destruction or scarring of the supervening tissue by such exposure.

5. A method according to claim 1 applied for endoscopic monitoring of the presence of one or more said chromophores in the tissue sample.

6. A method according to claim 1, further comprising:

processing data processed to normalize the defined parameter defined by the generated data to a standard value generated data using a predictive mathematical model of the optical properties of the biological tissue to normalize a further parameter; and

measuring at least one parameter of the tissue using said processed data processed to normalize the further parameter to a standard value.

7. A method in according to claim 1 wherein said sample of biological tissue comprises a sample of epithelial tissue having a thickness of papillary dermis, wherein using the generated data to define a parameter of the tissue comprises using the generated data to determine the thickness of papillary dermis of said tissue sample and processing the generated data using a predictive mathematical model of the optical properties of the biological tissue to normalize the defined parameter defined by the generated data to a standard value of that parameter comprises processing the generated data to generate data indicative of differences between incident light and light remitted by a tissue sample corresponding to the illuminated tissue sample where the papillary dermis of the sample is of a predetermined value.

9. A method according to claim 5 applied for endoscopic monitoring of the presence of one or more said chromophores in the tissue sample.

8. A method of deriving data relating to the presence and/or depth and/or concentration of any chromophore selected from the group consisting of:

melanin, blood, haemoglobin, oxy-haemoglobin, bilirubin, tatoo pigments and dyestuffs, keratin, collagen and hair, which method comprises;

illuminating an area of a tissue sample by projecting light from a light source;

receiving light remitted by the illuminated area of tissue at a photo-receptor;

spectroscopically analyzing the light projected from the light source and the remitted light received by the photo-receptor and utilizing said analysis to generate data indicative of differences between light projected from the light source and the remitted light;

using the generated data to define a parameter of the tissue;

processing the generated data using a predictive mathematical model of the optical properties of the biological tissue to normalize the defined parameter defined by the generated data to a standard value of that parameter; and

measuring at least one further parameter of the tissue relating to the presence and/or depth and/or concentration of any chromophore selected from the group consisting of;

melanin, blood, hemoglobin, oxy-hemoglobin, bilirubin, tattoo pigments and dyestuffs, keratin, collagen and hair using said processed data processed to normalize the defined parameter defined by the generated data to a standard value.

10. A method according to claim 8, further comprising:

processing data processed to normalize the defined parameter defined by the generated data to a standard value generated data using a predictive mathematical model of the optical properties of the biological tissue to normalize a further parameter; and

measuring at least one parameter of the tissue relating to the presence and/or depth and/or concentration of any chromophore selected from the group consisting of;

melanin, blood, hemoglobin, oxy-hemoglobin, bilirubin, tattoo pigments and dyestuffs, keratin, collagen and hair using said processed data processed to normalize the further parameter to a standard value.

11. A method of non-invasively analyzing tissue structure, comprising the steps of:

(i) measuring red or infrared radiation from at least one location in an area of tissue under investigation so as to give an indication of any layered structure in said area;

(ii) measuring the tissue color co-ordinates at said at least one location in said area of tissue;

(iii) using data obtained in measuring steps (i) and (ii) to calculate corrected tissue color co-ordinates in respect of said area which corresponds to a predetermined thickness of said layered structure, and;

(iv) comparing the corrected tissue color co-ordinates obtained in step (iii) with a reference color co-ordinate range for healthy tissue having a known layered structure of the same predetermined thickness.

12. A method according to claim 11, wherein said layered structure comprises a layer of collagen.

13. A method according to claim 11 where the light in section (i) extends across the UV and/or visible and/or IR regions.

14. A method according to claim 11, comprising the additional step of;

(v) identifying corrected tissue color co-ordinates which lie outside the reference color co-ordinate range.

15. A method according to claim 14, comprising the additional steps of;

(vi) comparing the degree of deviation of the corrected tissue color co-ordinates which lie outside the reference color co-ordinate range with generalized levels of deviation from a reference color co-ordinate range known to be associated with differing abnormalities in said tissue, and;

(vii) using the tissue color co-ordinates to assess the degree of abnormality of said tissue.

16. A method according to claim 14, comprising of additional steps of

(vi) calibrating the corrected tissue color co-ordinates with the corrected tissue co-ordinates of at least one tissue location having color co-ordinates lying within said reference color co-ordinate range for normal tissue;

(vii) using the tissue color co-ordinates to assess the degree of abnormality of said tissue.

17. A method according to claim 16, wherein said calibration in step (vi) includes estimating the level of epidermal melanin at said location by reference to epidermal melanin levels calculated within at least one normal skin region adjacent said location.

18. A method according to claim 15, wherein said calibration in step (vi) includes measuring epidermal melanin levels at said location by assessing the deviation at the blue end of the spectrum at said location from the reference color co-ordinate range for normal skin.

19. A method according to claim 14, wherein the tissue color co-ordinates at said at least one location in said area of tissue are measured in a manner which is blind to the presence of melanin.

20. A method according to claim 14, where the properties of polarized light are used to remove the effects of epidermal melanin.

21. A method according to claim 14, wherein in step (i) two red or infrared images, each at a different wavelength, are obtained for each of said locations, whereby to enable the effect of the presence of epidermal melanin and dermal blood and collagen to be accounted for in the calculation of step (iii).

22. A method according to claim 21, wherein said infrared image(s) is/are obtained using infrared photographic film, or laser(s) or by spectral analysis.

23. A method according to claim 14, wherein in step (i) two infrared images, each at a different wavelength, are obtained for each of said locations, thereby to enable the effect of the presence of epidermal melanin and dermal blood to be accounted for in the calculation of step (iii).

24. A method according to claim 11, wherein an independent measurement of the level of epidermal melanin is made.

25. A method according to claim 11, wherein in step (i), a single infrared image at a wavelength of greater than about 1100 nm is obtained for the or each said location.

26. A method according to claim 11, wherein the reference color co-ordinate range for normal tissue at the predetermined collagen layer thickness referred to in step (iv) is obtained as a curved surface lying within a three-dimensional color space, with a first bounding axis relating to the amount of a first chromophore within the collagen layer and a second bounding axis relating to the amount of a second chromophore within the collagen layer.

27. A method according to claim 26, wherein said collagen layer is the papillary dermis, said first chromophore is epidermal melanin and said second chromophore is blood.

28. A method according to claim 26, wherein said three-dimensional color space is selected from LMS, RGB and UV G IR color spaces.

29. A method according to claim 11, wherein the skin color co-ordinates of step (ii) are acquired from an image using the same lighting conditions and the same calibration set-up as used to produce the healthy skin reference color co-ordinate range.

30. A method according to claim 11, wherein the skin color co-ordinates of step (ii) are acquired from an image using different lighting conditions than used to obtain the healthy skin reference color co-ordinate range, and a white standard or other correction factor is used to allow calibration of the image with the reference color co-ordinate range.

31. A method according to claim 11, of deriving data relating to the presence, depth, and concentration of chromophores and creating and displaying a map thereof.

32. A method of mapping the papillary surface of an area of the dermis which comprises illuminating the surface of the skin over that area with light and monitoring the intensity of the light remitted from along at least one line or sequence of points, the light having a wavelength sufficiently far into the infra-red that its absorption by melanin and blood is negligible, and deriving therefrom a theoretical intensity of remitted light which is independent of the presence of melanin or blood, and from the remitted light intensity deriving a signal corresponding to the concentration of collagen within the papillary dermis along the or each line or at each point, and producing a contoured image in which the apparent elevation of any point is dependent upon the strength of such signal.

33. Apparatus for monitoring the presence of one or more chromophores in a biological tissue sample, which apparatus comprises:

a light source for projecting light to illuminate an area of such tissue sample,

a photo-receptor for receiving light remitted by an area of tissue, illuminated by said light source;

a spectroscopic analyzer for analyzing light projected from the light source and remitted light received by the photo-receptor and utilizing said analysis to generate data indicative of the differences between light projected from the light source and the remitted light;

a processor for processing data generated by said spectroscopic analyzer to define a parameter of the tissue and to process the generated data using a predictive mathematical model to normalize the defined parameter defined by the data generated by the spectroscopic analyzer to a standard value of that parameter and for utilizing data processed to normalize the defined parameter to measure at least one further parameter of the tissue and generate a control signal on the basis of said least one further parameter of the tissue.

34. Apparatus according to claim 33, wherein means is provided for passing said control signal to one or more of the following:

a display device such as a display monitor, a printer, or a medical laser or other treatment device or apparatus.

35. Apparatus according to claim 33, wherein said light source is arranged to illuminate an area of tissue with light having a wavelength in excess of 600 nm.

36. Apparatus according to claim 35, wherein said photo-receptor is operable to monitor light of wavelengths in the 800 to 1000 nm band and the 600 to 800 nm band.

37. Apparatus according to claim 33, wherein said light source, photo-receptor and spectroscopic analyzer are together adapted to measure at least one further parameter which is blind to the effects of melanin.

38. Apparatus according to claim 33, wherein said photo-receptor is operable to monitor the intensity of the light remitted from a plurality of lines or a two-dimensional array of points.

39. Apparatus according to claim 33, wherein said photo-receptor is operable to monitor the intensity of the light remitted with a resolution of at least 20 lines or dots per mm.

40. Apparatus according to claim 33, wherein an image of remitted light is captured using a digital camera in which use is made of a charge coupled device measuring 20×

15 mm or less with a resolution of 800×

600 pixels or more.

41. Apparatus according to claim 33, wherein a light guide of which at least part is flexible is provided for conducting light between said light source, said tissue sample and said photo-receptor.

42. Apparatus according to claim 33, wherein an endoscope is provided for conducting light between said light source, said tissue sample and said photo-receptor.

43. Apparatus according to claim 33, wherein means is provided for varying the size of the area of tissue monitored.

44. A method of mapping the papillary surface of an area of the dermis which comprises illuminating the surface of the skin over that area with light and monitoring the intensity of the light remitted from along at least one line or sequence of points, the light having at least two wavelengths of which at least one is in excess of 600 nm and deriving therefrom a theoretical intensity of remitted light which is independent of the presence of melanin or blood, and from the remitted light intensity deriving a signal corresponding to the concentration of collagen within the papillary dermis along the or each line or at each point, and producing a contoured image in which the apparent elevation of any point is dependent upon the strength of such signal.

45. Apparatus for mapping the papillary surface of an area of the dermis which comprises a light source illuminating the surface of the skin over that area with light which has at least two wavelengths of which at least one is in excess of 600 nm, means for monitoring the intensity of the light remitted along at least one line or sequence of points, and deriving therefrom an intensity or theoretical intensity of remitted light which is independent of the presence of melanin or blood, and means for deriving a signal from the remitted light intensity corresponding to the concentration of collagen within the papillary dermis along the or each line or at each point, and for producing a contoured image in which the apparent elevation of any point is dependent upon the strength of such signal.

46. A method of non-invasive monitoring the presence of one or more chromophores in a sample of biological tissue, and controlling a treatment which involves the irradiation of a region of tissue with treatment light of predetermined spectral characteristics which method comprises illuminating an area of such tissue sample by projecting light from a light source, receiving light remitted by the illuminated area of tissue at a photo-receptor, spectroscopically analyzing the remitted light, and comparing variations in the intensity and spectral characteristics of the remitted light with respect to the intensity and spectral characteristics of the projected light and with data representing a datum sample of intensity and spectral characteristics of light remitted by a sample of tissue of known structure and wherein the absorption characteristics of tissue supervening the region to be treated for the treatment light are measured and used in calculating a required exposure of the tissue to the treatment light.

47. A method of non-invasive monitoring the presence of one or more chromophores in a sample of biological tissue and for predicting the outcome of a treatment which involves the irradiation of a region of tissue with treatment light of predetermined spectral characteristics, which method comprises illuminating an area of such tissue sample by projecting light from a light source, receiving light remitted by the illuminated area of tissue at a photo-receptor, spectroscopically analyzing the remitted light, and comparing variations in the intensity and spectral characteristics of the remitted light with respect to the intensity and spectral characteristics of the projected light and with data representing a datum sample of intensity and spectral characteristics of light remitted by a sample of tissue of known structure, wherein the absorption characteristics for the treatment light of the tissue region to be treated and of tissue supervening the region to be treated are measured and used in calculating a required therapeutically effective exposure of the tissue to the treatment light, and the required exposure and the absorption characteristics of the supervening tissue are used to predict potential destruction or scarring of the supervening tissue by such exposure.